Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug ...
Forget copyright. In the age of AI, the real IP isn’t code; it’s conviction. Tomorrow’s market leaders won’t own the most ...